China Resources Zizhu Pharmaceutical Co., Ltd. clinical trials

A subsidiary of China Resources Pharmaceutical Group Limited

The registry lists 1 studies whose lead sponsor is China Resources Zizhu Pharmaceutical Co., Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 7, 2019.

Status

Terminated: 1

Phase

Phase 4: 1

Where

China: 1

Registry sponsor names on this page

China Resources Zizhu Pharmaceutical Co., Ltd.1 study

Something wrong with this grouping? Tell us on the China Resources Pharmaceutical Group Limited page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All China Resources Pharmaceutical Group Limited studies →

A Study on the Mifepristone Tablets in the Treatment of Symptomatic Uterine Fibroids With Safety and EfficacyTerminatedNCT03210324Phase 4
Sponsor listed in the registry: China Resources Zizhu Pharmaceutical Co., Ltd.